SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-029494
Filing Date
2022-11-10
Accepted
2022-11-10 16:15:15
Documents
15
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20221110.htm   iXBRL 8-K 35087
2 EX-99.1 exh9912022q3earningsrelease.htm EX-99.1 88868
7 bellicumpressrel_image1a01.gif GRAPHIC 21803
  Complete submission text file 0001628280-22-029494.txt   325262

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20221110.xsd EX-101.SCH 2156
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20221110_def.xml EX-101.DEF 14380
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20221110_lab.xml EX-101.LAB 27854
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20221110_pre.xml EX-101.PRE 14917
9 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20221110_htm.xml XML 10775
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 221377383
SIC: 2834 Pharmaceutical Preparations